Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation

References

• BrookmeyerREvansDAHebertLNational estimates of the prevalence of Alzheimer’s disease in the United StatesAlzheimers Dement201171617321255744
   PubMed Web of Science ®Google Scholar
• IizukaTShojiMKawarabayashiTIntracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretaseBiochem Biophys Res Commun199621812382428573139
   PubMed Web of Science ®Google Scholar
• NesiGSestitoSDigiacomoMRapposelliSOxidative stress, mitochondrial abnormalities and proteins deposition: multitarget approaches in Alzheimer’s diseaseCurr Top Med Chem201717273062307928595557
   PubMed Web of Science ®Google Scholar
• PocernichCBLangeMLSultanaRButterfieldDANutritional approaches to modulate oxidative stress in Alzheimer’s diseaseCurr Alzheimer Res20118545246921605052
   PubMed Web of Science ®Google Scholar
• NorstromEMetabolic processing of the amyloid precursor protein – new pieces of the Alzheimer’s puzzleDiscov Med20172312726927628595039
   PubMed Web of Science ®Google Scholar
• OmtriRSThompsonKJTangXDifferential effects of Alzheimer’s disease Aβ40 and 42 on Endocytosis and intraneuronal traffickingNeuroscience201837315916829337241
   PubMed Web of Science ®Google Scholar
• YoshiyamaYLeeVMTrojanowskiJQTherapeutic strategies for tau mediated neurodegenerationJ Neurol Neurosurg Psychiatry201384778479523085937
   PubMed Web of Science ®Google Scholar
• AlonsoADDi ClericoJLiBPhosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegenerationJ Biol Chem201028540308513086020663882
   PubMed Web of Science ®Google Scholar
• NelsonPTAlafuzoffIBigioEHCorrelation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literatureJ Neuropathol Exp Neurol201271536238122487856
   PubMed Web of Science ®Google Scholar
• UdeochuJCSheaJMVilledaSAMicroglia communication: parallels between aging and Alzheimer’s diseaseClin Exp Neuroimmunol20167211412527840659
   PubMedGoogle Scholar
• YeSMJohnsonRWIncreased interleukin-6 expression by microglia from brain of aged miceJ Neuroimmunol1999931–213914810378877
   PubMed Web of Science ®Google Scholar
• RitzelRMPatelARPanSAge- and location-related changes in microglial functionNeurobiol Aging20153662153216325816747
   PubMed Web of Science ®Google Scholar
• LinHQHoMTLauLSWongKKShawPCWanDCAnti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer’s diseaseChem Biol Interact20081751–335235418573242
   PubMed Web of Science ®Google Scholar
• HaasCStrategies, development, and pitfalls of therapeutic options for Alzheimer’s diseaseJ Alzheimers Dis201228224128121987594
   PubMed Web of Science ®Google Scholar
• BeckerREGreigNHAlzheimer’s disease drug development: old problems require new prioritiesCNS Neurol Disord Drug Targets20087649951119128207
   PubMed Web of Science ®Google Scholar
• GosseletFSaint-PolJCandelaPFenartLAmyloid-β peptides, Alzheimer’s disease and the blood-brain barrierCurr Alzheimer Res201310101015103324156262
   PubMed Web of Science ®Google Scholar
• MawuenyegaKGSigurdsonWOvodVDecreased clearance of CNS beta-amyloid in Alzheimer’s diseaseScience20103306012177421148344
   PubMed Web of Science ®Google Scholar
• van AssemaDMLubberinkMBauerMBlood-brain barrier P-glycoprotein function in Alzheimer’s diseaseBrain2012135Pt 118118922120145
   PubMed Web of Science ®Google Scholar
• JedlitschkyGVogelgesangSKroemerHKMDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer’s diseaseClin Pharmacol Ther201088444144320856238
   PubMed Web of Science ®Google Scholar
• CascorbiIFlühCRemmlerCAssociation of ATP-binding cassette transporter variants with the risk of Alzheimer’s diseasePharmacogenomics201314548549423556446
   PubMed Web of Science ®Google Scholar
• BrennAGrubeMPetersMBeta-amyloid downregulates MDR1-P-Glycoprotein (Abcb1) expression at the blood-brain barrier in miceInt J Alzheimers Dis2011201169012169012621660212
   PubMedGoogle Scholar
• NeuweltEABauerBFahlkeCEngaging neuroscience to advance translational research in brain barrier biologyNat Rev Neurosci201112316918221331083
   PubMed Web of Science ®Google Scholar
• WolfABauerBHartzAMABC Transporters and the Alzheimer’s disease enigmaFront Psychiatry20123545422675311
   PubMedGoogle Scholar
• De StrooperBKarranEThe cellular phase of Alzheimer’s diseaseCell2016164460361526871627
   PubMed Web of Science ®Google Scholar
• PratiFBottegoniGBolognesiMLCavalliABACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer’s diseaseJ Med Chem201861361963728749667
   PubMed Web of Science ®Google Scholar
• GoldMPhase II clinical trials of anti-amyloid β antibodies: when is enough, enough?Alzheimers Dement201733402409
   Google Scholar
• LengJQinHLZhuKEvaluation of multifunctional synthetic tetralone derivatives for treatment of Alzheimer’s diseaseChem Biol Drug Des201688688989827434226
   PubMed Web of Science ®Google Scholar
• XieSChenJLiXSynthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer’s diseaseBioorg Med Chem201523133722372925934229
   PubMed Web of Science ®Google Scholar
• XiaNLiuLNingXLinLMetallothioneins and synthetic metal chela-tors as potential therapeutic agents for removal of aberrant metal ions from metal-Aβ speciesMini Rev Med Chem201414327128124456271
   PubMed Web of Science ®Google Scholar
• BahramikiaSYazdanparastRInhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivativesEur J Pharmacol20137071–3172523528352
   PubMed Web of Science ®Google Scholar
• DeyABhattacharyaRMukherjeeAPandeyDKNatural products against Alzheimer’s disease: Pharmaco-therapeutics and biotechnological interventionsBiotechnol Adv201735217821628043897
   PubMed Web of Science ®Google Scholar
• Sandoval-AcuñaCFerreiraJSpeiskyHPolyphenols and mitochondria: an update on their increasingly emerging ROS-scavenging independent actionsArch Biochem Biophys2014559759024875147
   PubMed Web of Science ®Google Scholar
• BeghynTDeprez-PoulainRWillandNFolleasBDeprezBNatural compounds: leads or ideas? Bioinspired molecules for drug discoveryChem Biol Drug Des200872131518554253
   PubMed Web of Science ®Google Scholar
• GarciaEJOldoniTLAlencarSMReisALoguercioADGrandeRHAntioxidant activity by DPPH assay of potential solutions to be applied on bleached teethBraz Dent J2012231222722460310
   PubMedGoogle Scholar
• FarinaNLlewellynDIsaacMTabetNVitamin E for Alzheimer’s dementia and mild cognitive impairmentCochrane Database Syst Rev201744CD00285428418065
   PubMedGoogle Scholar
• SezginZDincerYAlzheimer’s disease and epigenetic dietNeurochem Int20147810511625290336
   PubMed Web of Science ®Google Scholar
• ZhangLNSunYJPanSNa+-K+-ATPase, a potent neuroprotective modulator against Alzheimer diseaseFundam Clin Pharmacol20132719610323033963
   PubMed Web of Science ®Google Scholar
• AlamPChaturvediSKSiddiqiMKVitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseasesSci Rep201662675927230476
   PubMed Web of Science ®Google Scholar
• MizwickiMTMenegazDZhangJGenomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer’s disease macrophagesJ Alzheimers Dis2012291516222207005
   PubMed Web of Science ®Google Scholar
• RigacciSStefaniMNutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenolsExpert Rev Neurother2015151415225418871
   PubMed Web of Science ®Google Scholar
• SawikrYYarlaNSPelusoIKamalMAAlievGBishayeeAChapter two – neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticalsDonevRAdvances in Protein Chemistry and Structural BiologyMassachusettsAcademic Press20173357
   Google Scholar
• LodiASahaALuXCombinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolismNPJ Precis Oncol201711pii18
   Google Scholar
• ZasadilLMAndersenKAYeumDCytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindlesSci Transl Med20146229229ra43
   PubMed Web of Science ®Google Scholar
• MclaurinJGolombRJurewiczAAntelJPFraserPEInositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicityJ Biol Chem200027524184951850210764800
   PubMed Web of Science ®Google Scholar
• MclaurinJKiersteadMEBrownMECyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse modelNat Med200612780180816767098
   PubMed Web of Science ®Google Scholar
• LaiAYMcLaurinJInhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer diseaseBiochim Biophys Acta20121822101629163722800931
   PubMed Web of Science ®Google Scholar
• ShanmugamMKRaneGKanchiMMThe multifaceted role of curcumin in cancer prevention and treatmentMolecules20152022728276925665066
   PubMed Web of Science ®Google Scholar
• CianciulliACalvelloRPorroCTrottaTSalvatoreRPanaroMAPI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microgliaInt Immunopharmacol20163628229027208432
   PubMed Web of Science ®Google Scholar
• EsmailyHSahebkarAIranshahiMAn investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trialChin J Integr Med201521533233825776839
   PubMed Web of Science ®Google Scholar
• MattsonMPSonTGCamandolaSViewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicalsDose Response20075317418618648607
   PubMedGoogle Scholar
• GhoshSBanerjeeSSilPCThe beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent updateFood Chem Toxicol20158311112426066364
   PubMed Web of Science ®Google Scholar
• AlamMNBristiNJRafiquzzamanMReview on in vivo and in vitro methods evaluation of antioxidant activitySaudi Pharm J201321214315224936134
   PubMed Web of Science ®Google Scholar
• DoharePVarmaSRayMCurcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injuryNitric Oxide200819111118485279
   PubMed Web of Science ®Google Scholar
• DoharePGargPJainVNathCRayMDose dependence and therapeutic window for the neuroprotective effects of curcumin in throm-boembolic model of ratBehav Brain Res2008193228929718611416
   PubMed Web of Science ®Google Scholar
• ZhangLJWuCFMengXLComparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharideNeurosci Lett20084471485318838107
   PubMed Web of Science ®Google Scholar
• AtaieASabetkasaeiMHaghparastAMoghaddamAHKazeminejadBNeuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the ratPharmacol Biochem Behav201096437838520619287
   PubMed Web of Science ®Google Scholar
• AbeYHashimotoSHorieTCurcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophagesPharmacol Res1999391414710051376
   PubMed Web of Science ®Google Scholar
• BhartiACDonatoNAggarwalBBCurcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cellsJ Immunol200317173863387114500688
   PubMed Web of Science ®Google Scholar
• ShiXZhengZLiJCurcumin inhibits Aβ-induced microglial inflammatory responses in vitro: involvement of ERK1/2 and p38 signaling pathwaysNeurosci Lett201559410511025818332
   PubMed Web of Science ®Google Scholar
• StankowskaDLKrishnamoorthyVREllisDZKrishnamoorthyRRNeuroprotective effects of curcumin on endothelin-1 mediated cell death in hippocampal neuronsNutr Neurosci201720527328326651837
   PubMed Web of Science ®Google Scholar
• WangCZhangXTengZZhangTLiYDownregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic miceEur J Pharmacol201474031232025041840
   PubMed Web of Science ®Google Scholar
• ZhangLFangYXuYCurcumin improves amyloid β-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathwayPLoS One2015106e013152526114940
   PubMed Web of Science ®Google Scholar
• XiongZHongmeiZLuSYuLCurcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s diseasePharmacol Rep20116351101110822180352
   PubMed Web of Science ®Google Scholar
• TangMTaghibiglouCThe mechanisms of action of curcumin in Alzheimer’s diseaseJ Alzheimers Dis20175841003101628527218
   PubMed Web of Science ®Google Scholar
• UdeCSchubert-ZsilaveczMWurglicsMGinkgo biloba extracts: a review of the pharmacokinetics of the active ingredientsClin Pharmacokinet201352972774923703577
   PubMed Web of Science ®Google Scholar
• AugustinSRimbachGAugustinKSchliebsRWolfframSCermakREffect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer’s diseaseArch Biochem Biophys2009481217718218996078
   PubMed Web of Science ®Google Scholar
• Abdel-KaderRHauptmannSKeilUStabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)Pharmacol Res200756649350217977008
   PubMed Web of Science ®Google Scholar
• BastianettoSZhengWHQuirionRThe Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicityJ Neurochem20007462268227710820186
   PubMed Web of Science ®Google Scholar
• ShiCWuFXuJH2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761Neurochem Int201056889390520362023
   PubMed Web of Science ®Google Scholar
• YoshitakeTYoshitakeSKehrJThe Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortexBr J Pharmacol2010159365966820105177
   PubMed Web of Science ®Google Scholar
• JangJYMinJHWangSBResveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2Free Radic Biol Med20158984285126482867
   PubMed Web of Science ®Google Scholar
• CianciulliADragoneTCalvelloRIL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cellsInt Immunopharmacol201524236937625576658
   PubMed Web of Science ®Google Scholar
• JhangKAParkJSKimHSChongYHResveratrol ameliorates tau hyperphosphorylation at Ser396 site and oxidative damage in rat hippocampal slices exposed to vanadate: implication of ERK1/2 and GSK-3β signaling cascadesJ Agric Food Chem201765449626963429022339
   PubMed Web of Science ®Google Scholar
• WangGChenLPanXThe effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signalingOncotarget2016714173801739226980711
   PubMedGoogle Scholar
• FengXLiangNZhuDResveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathwayPLoS One201383e5988823555824
   PubMed Web of Science ®Google Scholar
• LadiwalaARLinJCBaleSSResveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformersJ Biol Chem201028531242282423720511235
   PubMed Web of Science ®Google Scholar
• WangJHoLZhaoZModerate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer’s diseaseFASEB J200620132313232017077308
   PubMed Web of Science ®Google Scholar
• RingmanJMFrautschySATengEOral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled studyAlzheimers Res Ther2012454323107780
   PubMed Web of Science ®Google Scholar
• QuinnJFRamanRThomasRGDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trialJAMA2010304171903191121045096
   PubMed Web of Science ®Google Scholar
• SallowaySSperlingRKerenRA phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseNeurology201177131253126221917766
   PubMed Web of Science ®Google Scholar
• KayeJDekoskySTWilliamsonJDGinkgo biloba for prevention of dementia: a randomized controlled trialArch Neurol200966565265419433666
   PubMedGoogle Scholar
• DekoskySTWilliamsonJDFitzpatrickALSnitzBEO’MearaESCarlsonMCGinkgo biloba for prevention of dementia: a randomized controlled trialJAMA2008300192663267019066386
   PubMed Web of Science ®Google Scholar
• YallapuMMNageshPKJaggiMChauhanSCTherapeutic applications of curcumin nanoformulationsAaps J20151761341135626335307
   PubMed Web of Science ®Google Scholar
• KankalaRKTsaiPYKuthatiYWeiPRLiuCLLeeCHOvercoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeuticsJ Mater Chem B20175715071517
   PubMed Web of Science ®Google Scholar
• KankalaRKLiuCGChenAZOvercoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactorsACS Biomater Sci Eng201731024312442
   PubMed Web of Science ®Google Scholar
• ComogluTArisoySAkkusZBNanocarriers for effective brain drug deliveryCurr Top Med Chem201717131490150628017157
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• YehYCCreranBRotelloVMGold nanoparticles: preparation, properties, and applications in bionanotechnologyNanoscale2012461871188022076024
   PubMed Web of Science ®Google Scholar
• MurphyCJGoleAMStoneJWGold nanoparticles in biology: beyond toxicity to cellular imagingAcc Chem Res200841121721173018712884
   PubMed Web of Science ®Google Scholar
• HuangXEl-SayedMAGold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapyJ Adv Res2010111328
   Google Scholar
• LohseSEMurphyCJApplications of colloidal inorganic nanoparticles: from medicine to energyJ Am Chem Soc201213438156071562022934680
   PubMed Web of Science ®Google Scholar
• JanaNREarhartCYingJYSynthesis of water-soluble and functionalized nanoparticles by silica coatingChem Mater2007192150745082
   Web of Science ®Google Scholar
• NagahamaKUtsumiTKumanoTMaekawaSOyamaNKawakamiJDiscovery of a new function of curcumin which enhances its anticancer therapeutic potencySci Rep201663096227476814
   PubMed Web of Science ®Google Scholar
• ManjuSSreenivasanKGold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cellsJ Colloid Interface Sci2012368114415122200330
   PubMed Web of Science ®Google Scholar
• DeySSreenivasanKConjugating curcumin to water soluble polymer stabilized gold nanoparticles via pH responsive succinate linkerJ Mater Chem B201535824833
   PubMed Web of Science ®Google Scholar
• PalmalSMaityARSinghBKBasuSJanaNRInhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin-gold nanoparticlesChemistry201420206184619124691975
   PubMed Web of Science ®Google Scholar
• JayaramDTShankarBHRamaiahDEffective amyloid defibrillation by polyhydroxyl-substituted squaraine dyesChem Asian J201510122689269426289494
   PubMed Web of Science ®Google Scholar
• ChandraBMaityBKDasAMaitiSFluorescence quenching by lipid encased nanoparticles shows that amyloid-β has a preferred orientation in the membraneChem Commun2018545677507753
   PubMed Web of Science ®Google Scholar
• PeppasNABuresPLeobandungWIchikawaHHydrogels in pharmaceutical formulationsEur J Pharm Biopharm2000501274610840191
   PubMed Web of Science ®Google Scholar
• SoniGYadavKSNanogels as potential nanomedicine carrier for treatment of cancer: a mini review of the state of the artSaudi Pharm J201624213313927013905
   PubMed Web of Science ®Google Scholar
• YcYFunkeWReactive microgels by emulsion polymerization of unsaturated polyester resinsAngew Makromol Chem19821031187202
   Google Scholar
• LiangFWFunkeWCross-linking self-emulsifying copolymerization of an unsaturated polyester and styreneMacromolecules1996292786508655
   Web of Science ®Google Scholar
• VinogradovSVBronichTKKabanovAVNanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cellsAdv Drug Deliv Rev200254113514711755709
   PubMed Web of Science ®Google Scholar
• KabanovAVVinogradovSVNanogels as pharmaceutical carriers: finite networks of infinite capabilitiesAngew Chem Int Ed Engl200948305418542919562807
   PubMed Web of Science ®Google Scholar
• WeiXSenanayakeTHBohlingAVinogradovSVTargeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibitionMol Pharm20141193112312225072100
   PubMedGoogle Scholar
• JiangZDongXLiuHWangYZhangLSunYMultifunctionality of self-assembled nanogels of curcumin-hyaluronic acid conjugates on inhibiting amyloid β-protein fibrillation and cytotoxicityReact Funct Polym20161042229
   Web of Science ®Google Scholar
• ManjuSSreenivasanKConjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stabilityJ Colloid Interface Sci2011359131832521492865
   PubMed Web of Science ®Google Scholar
• WangYJPanMHChengALStability of curcumin in buffer solutions and characterization of its degradation productsJ Pharm Biomed Anal19971512186718769278892
   PubMed Web of Science ®Google Scholar
• KreuterJNanoparticles – a historical perspectiveInt J Pharm2007331111017110063
   PubMed Web of Science ®Google Scholar
• CouvreurPPolyalkylcyanoacrylates as colloidal drug carriersCrit Rev Ther Drug Carrier Syst1988511203293806
   PubMed Web of Science ®Google Scholar
• X-YLuD-CWuZ-JLiG-QChenPolymer nanoparticlesVillaverdeAProgress in Molecular Biology and Translational ScienceMassachusettsAcademic Press2011299323
   Google Scholar
• ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
   PubMed Web of Science ®Google Scholar
• WaghelaBNSharmaADhumaleSPandeySMPathakCCurcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cellsPLoS One2015102e011752625692854
   PubMed Web of Science ®Google Scholar
• YangXLiZWangNCurcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivoSci Rep201551032225980982
   PubMed Web of Science ®Google Scholar
• GouMMenKShiHCurcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivoNanoscale2011341558156721283869
   PubMed Web of Science ®Google Scholar
• MulikRSMönkkönenJJuvonenROMahadikKRParadkarARApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture modelMol Pharm20107381582520230014
   PubMedGoogle Scholar
• MathewAFukudaTNagaokaYCurcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s diseasePLoS One201273e3261622403681
   PubMed Web of Science ®Google Scholar
• Djiokeng PakaGDogguiSZaghmiANeuronal uptake and neuroprotective properties of curcumin-loaded nanoparticles on SK-N-SH cell line: role of poly(lactide-co-glycolide) polymeric matrix compositionMol Pharm201613239140326618861
   PubMedGoogle Scholar
• DogguiSSahniJKArseneaultMDaoLRamassamyCNeuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell lineJ Alzheimers Dis201230237739222426019
   PubMed Web of Science ®Google Scholar
• PakaGDRamassamyCOptimization of curcumin-loaded PEG-PLGA nanoparticles by GSH functionalization: investigation of the internalization pathway in neuronal cellsMol Pharm20171419310627744707
   PubMedGoogle Scholar
• BanghamADStandishMMWatkinsJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
   PubMed Web of Science ®Google Scholar
• SessaGWeissmannGIncorporation of lysozyme into liposomes. A model for structure-linked latencyJ Biol Chem197024513329533015459633
   PubMed Web of Science ®Google Scholar
• GregoriadisGThe carrier potential of liposomes in biology and medicine (second of two parts)N Engl J Med197629514765770785256
   PubMed Web of Science ®Google Scholar
• JainSJainVMahajanSCLipid based vesicular drug delivery systemsAdv Pharm201420147112
   Google Scholar
• LazarANMourtasSYoussefICurcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer diseaseNanomedicine20139571272123220328
   PubMed Web of Science ®Google Scholar
• MourtasSCanoviMZonaCCurcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptideBiomaterials20113261635164521131044
   PubMed Web of Science ®Google Scholar
• SummerlinNSooEThakurSQuZJambhrunkarSPopatAResveratrol nanoformulations: challenges and opportunitiesInt J Pharm2015479228229025572692
   PubMed Web of Science ®Google Scholar
• RichardTPawlusADIglésiasMLNeuroprotective properties of resveratrol and derivativesAnn N Y Acad Sci20111215110310821261647
   PubMedGoogle Scholar
• FrozzaRLBernardiAHoppeJBNeuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsulesMol Neurobiol20134731066108023315270
   PubMed Web of Science ®Google Scholar
• LoureiroJAndradeSDuarteAResveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s diseaseMolecules2017222277
   PubMed Web of Science ®Google Scholar
• NevesARQueirozJFReisSBrain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein EJ Nanobiotechnology20161412727061902
   PubMed Web of Science ®Google Scholar
• HeXPDengQCaiLFluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer’s diseaseACS Appl Mater Interfaces2014685379538224702005
   PubMed Web of Science ®Google Scholar
• AnsariMAAbdulHMJoshiGOpiiWOButterfieldDAProtective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer’s diseaseJ Nutr Biochem200920426927518602817
   PubMed Web of Science ®Google Scholar
• NdayCMHalevasEJacksonGESalifoglouAQuercetin encapsulation in modified silica nanoparticles: potential use against Cu(II)-induced oxidative stress in neurodegenerationJ Inorg Biochem2015145516425634813
   PubMed Web of Science ®Google Scholar
• SunDLiNZhangWDesign of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s diseaseColloids Surf B Biointerfaces201614811612927591943
   PubMed Web of Science ®Google Scholar
• BianchettiARozziniRTrabucchiMEffects of acetyl-L-carnitine in Alzheimer’s disease patients unresponsive to acetylcholinesterase inhibitorsCurr Med Res Opin200319435035312841930
   PubMed Web of Science ®Google Scholar
• HudsonSTabetNAcetyl-L-carnitine for dementiaCochrane Database Syst Rev200322CD003158
   Google Scholar
• PengYSunJHonSL-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer’s diseaseJ Neurosci201030248180818920554868
   PubMed Web of Science ®Google Scholar
• PittJThornerMBrautiganDLarnerJKleinWLProtection against the synaptic targeting and toxicity of Alzheimer’s-associated Aβ oligomers by insulin mimetic chiro-inositolsFASEB J201327119920723073831
   PubMed Web of Science ®Google Scholar
• CascellaMBimonteSMuzioMRSchiavoneVCuomoAThe efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practiceInfect Agent Cancer2017123628642806
   PubMed Web of Science ®Google Scholar
• TurnerRSThomasRGCraftSA randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer diseaseNeurology201585161383139126362286
   PubMed Web of Science ®Google Scholar
• YangGWangYTianJLiuJPHuperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trialsPLoS One201389e7491624086396
   PubMed Web of Science ®Google Scholar